Annual and quarterly planning
Plan your roadmap and deliver on your key R&D goals
Asset planning
Visualize key milestones in one place. Optimize resource allocation and identify potential bottlenecks.
Flexible reporting
Generate up to date, presentation-ready reports summarizing key outcomes for stakeholders.
Centralized knowledge hub
Break down information silos by aggregating data, plans, and historical results in a single accessible location.
State of the art data security
SOC 2 Type 2
Certified
Certified
21 CFR Part 11
Compliant
Compliant
AES-256 bit
encryption
encryption
MFA and
SAML SSO
SAML SSO
The tool of choice for ambitious R&D teams
“Kaleidoscope allows the discovery team to make faster and better-informed decisions because they have all the data at their fingertips.”
Ewan Taylor
CSO and Co-founder
CSO and Co-founder
“Kaleidoscope provides the ability to align our key partners, and effectively manage our growing portfolio of IP. It saves us 10 or more hours per week.”
Marina Crowe
Chief of Staff
Chief of Staff
“We needed a better system for tracking our R&D data and progress — Kaleidoscope enables more efficient decision making and communication to key stakeholders.”
Geraldine Paulus
Co-founder, VP Operations
Co-founder, VP Operations
“Kaleidoscope expertly streamlines our data sharing with CROs, making sure Psivant remains in perfect harmony.”
Shivam Patel
Head of Data Science & ML
Head of Data Science & ML
“Powerful, intuitive, well-designed ... lets biotechs spend resources on their actual IP: the assets and biology.”
Brian Naughton
Co-founder and CTO
Co-founder and CTO
“We realized that sharing our data in Kaleidoscope was really attractive to Pharma partners – it showed clarity of progress and that we have clean and organized data to work with.”
SVP Business Development
Platform Tx company with multi-asset pipeline
Platform Tx company with multi-asset pipeline
“Prior to Kaleidoscope it would take me 4-5 steps per workflow to do what I can now achieve in one step. I’m also able to spend 3x less time each week searching for, collating, and navigating data.”
Director of Preclinical Operations
Early stage small molecule therapeutics company
Early stage small molecule therapeutics company